Notice: This version of the RCU Marketplace is no longer accepting new listings.
We have a brand new, easy to use RCU Marketplace
Come take a look. On April 5, 2018, once all existing listings have expired, the old marketplace will close for good. In the meantime, feel free to browse what is for sale here, but please make any new for-sale or trade listing in the new Marketplace!
Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. Antibody-drug conjugates (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature.
With Ph.D. level scientists and over a decade of experience in recombinant antibody production, antibody engineering, synthetic chemistry, and bio-conjugation, Creative Biolabs is dedicated to serve the unique needs of our clients in ADC drug development projects by providing customized services that are tailored to meet your R&D timeline and budge